Home Transgene

Transgene

acquired
Post-IPO Round
Comprehensive Biopharmaceutical Company
Basic
Enterprise Profile

Basic Information

Transgene is a fully integrated biopharmaceutical company focused on designing and developing cutting-edge immunotherapy products for the treatment of cancer and chronic infectious diseases. Their expertise spans all stages of product development, from research to clinical-scale manufacturing and conducting clinical trials.
Transgene SA
Strasbourg,GreatEast,France
more than 500 people
January 01, 1979
communication@transgene.fr

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Gene Technology Biotechnology
Concept
Infectious Diseases Department Disease Treatment # Liver Cancer Cervical Cancer Gastric Cancer Colorectal Cancer
Application Scenarios
Innovative Drugs Prescription Drug Nucleic Acid Drugs